With the analysis among 1,818 patents, we discovered top 438 key players by total patent application. F. Hoffmann-La Roche Ltd., Ranbaxy Laboratories Ltd., Merck Patent GmbH are dominant in this area. They take 7.37% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Ranbaxy Laboratories Ltd.
Hessen, Germany
Patent: 36
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 32
Aichi-ken, Japan
Patent: 28
Indiana, United States
Patent: 26
New Jersey, United States
Patent: 25
Basel-Stadt, Switzerland
Patent: 25
New York, United States
Patent: 24
With the analysis among 30 patents, we discovered top 4 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Elysium Health, Inc., Nobilis Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 1
Nobilis Therapeutics, Inc.
Oregon, United States
Patent: 1
Noord-Brabant, Netherlands
Patent: 1
With the analysis among related 112 patents applied in the last 5 years. We discover 60 most active companies in this area. The fast-growing Qingdao Yangshen Biopharmaceutical Co., Ltd., Ningxia Medical University, Soochow University take 9.82% of patent filing during this period.
Qingdao Yangshen Biopharmaceutical Co., Ltd.
Shandong Sheng, China
Patent: 4
Ningxia Medical University
Ningxia Huizi Zizhiqu, China
Patent: 4
Jiangsu Sheng, China
Patent: 3
Changsha Manwang Biological Engineering Co., Ltd.
Hunan Sheng, China
Patent: 3
Indiana, United States
Patent: 3
The Third Affiliated Hospital of Guangzhou Medical University (Guangzhou Severe Maternity Treatment Center, Guangzhou Rouji Hospital)
undefined undefined
Patent: 2
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Institute Of Traditional Chinese Medicine Chinese Academy Of Traditional Chinese Medicine
undefined undefined
Patent: 2
Sun Yixian Memorial Hospital of Sun Yat sen University
undefined undefined
Patent: 2
Shandong First Medical University
Shandong Sheng, China
Patent: 2
With the analysis among related 112 patents in last 5 years, we discover 39 new entrants. Qingdao Yangshen Biopharmaceutical Co., Ltd., Changsha Manwang Biological Engineering Co., Ltd., The Third Affiliated Hospital of Guangzhou Medical University (Guangzhou Severe Maternity Treatment Center, Guangzhou Rouji Hospital) are the most active new entrants in this area.
Qingdao Yangshen Biopharmaceutical Co., Ltd.
Shandong Sheng, China
Patent: 4
Changsha Manwang Biological Engineering Co., Ltd.
Hunan Sheng, China
Patent: 3
The Third Affiliated Hospital of Guangzhou Medical University (Guangzhou Severe Maternity Treatment Center, Guangzhou Rouji Hospital)
undefined undefined
Patent: 2
Guangdong Sheng, China
Patent: 2
Sichuan Provincial People's Hospital
Sichuan Sheng, China
Patent: 2
Changzhou Second People's Hospital
undefined undefined
Patent: 2
Shandong First Medical University
Shandong Sheng, China
Patent: 2
Nossa United (Beijing) Biomedical Technology Co., Ltd.
Beijing Shi, China
Patent: 1
Beijing Institute of Genomics, Chinese Academy of Sciences
Beijing Shi, China
Patent: 1
With the analysis among 544 patents, we discovered top 105 universities and scientific research institutions by total patent application. Université d'Aix-Marseille, Kyoto University, Queen Mary University of London are dominant in this area. They take 12.13% of the total patent filing.
Université d'Aix-Marseille
Queen Mary University of London
Charité - Universitätsmedizin Berlin
Université Toulouse III - Paul Sabatier
Niedersachsen, Germany
Patent: 5